Explore

Trendline Trendline
Magnolia Oil Gas Leads Bid to Acquire WildFire Energy for Over $4 Billion

Magnolia Oil Gas Leads Bid to Acquire WildFire Energy for Over $4 Billion

Magnolia Oil Gas Leads Bid to Acquire WildFire Energy for Over $4 Billion
Trendline Trendline
Curium and Lantheus Announce $8 Billion Merger Agreement

Curium and Lantheus Announce $8 Billion Merger Agreement

Curium and Lantheus Announce $8 Billion Merger Agreement
Trendline Trendline
AstraZeneca Shares Drop Amid Merger Talks with Bristol Myers Squibb

AstraZeneca Shares Drop Amid Merger Talks with Bristol Myers Squibb

AstraZeneca Shares Drop Amid Merger Talks with Bristol Myers Squibb
Trendline Trendline
EA Acquired by Saudi Arabia and Jared Kushner's Affinity Partners in $55 Billion Deal

EA Acquired by Saudi Arabia and Jared Kushner's Affinity Partners in $55 Billion Deal

EA Acquired by Saudi Arabia and Jared Kushner's Affinity Partners in $55 Billion Deal
Reuters Reuters
P&G buys supplements maker Thorne for $3.8 billion as wellness push intensifies

P&G buys supplements maker Thorne for $3.8 billion as wellness push intensifies

By Alexander Marrow and Juveria Tabassum Aug 4 (Reuters) - Procter & Gamble is acquiring supplements maker Thorne for $3.8 billion in cash from LVMH-backed private equity firm L Catterton, the companies said on Tuesday, as the consumer goods giant deepens its push into health and wellness to
Trendline Trendline
AstraZeneca Explores Potential Merger with Bristol Myers Squibb Amid Patent Concerns

AstraZeneca Explores Potential Merger with Bristol Myers Squibb Amid Patent Concerns

AstraZeneca Explores Potential Merger with Bristol Myers Squibb Amid Patent Concerns
Reuters Reuters
AstraZeneca investors baulk at $400 billion Bristol Myers talks

AstraZeneca investors baulk at $400 billion Bristol Myers talks

By Maggie Fick LONDON, Aug 3 (Reuters) - AstraZeneca's shares fell sharply on Monday as investors baulked at reports of merger talks with Bristol Myers Squibb about forming what would become one of the world's biggest drugmakers with a combined value of nearly $400 billion.
Trendline Trendline
AstraZeneca and Bristol Myers Squibb in Talks for $400 Billion Merger

AstraZeneca and Bristol Myers Squibb in Talks for $400 Billion Merger

AstraZeneca and Bristol Myers Squibb in Talks for $400 Billion Merger
Trendline Trendline
Hilton Foods Sells Dalco to LiveKindly Collective Amid Strategic Shift

Hilton Foods Sells Dalco to LiveKindly Collective Amid Strategic Shift

Hilton Foods Sells Dalco to LiveKindly Collective Amid Strategic Shift
Reuters Reuters
AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says

AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says

By Sabrina Valle and Michael Erman Aug 2 (Reuters) - AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a possible combination that would create one of the world's biggest pharmaceutical companies with a combined value of nearly $400 billion, according to a person familiar
Reuters Reuters
UBS fined $125 million by US regulators for money laundering violations

UBS fined $125 million by US regulators for money laundering violations

By Jonathan Stempel NEW YORK, Aug 3 (Reuters) - UBS was fined $125 million by U.S. regulators on Monday for violating the Bank Secrecy Act, the largest civil fine ever against a broker-dealer for violating the main U.S. anti-money laundering law. The U.S.
Trendline Trendline
Nathan Kirsh's Wealth Surges as Restaurant Depot Sale Nears Completion

Nathan Kirsh's Wealth Surges as Restaurant Depot Sale Nears Completion

Nathan Kirsh's Wealth Surges as Restaurant Depot Sale Nears Completion